Endocyte (ECYT) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte (NASDAQ: ECYT) reported Q2 EPS of ($0.33), $0.07 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Endocyte (ECYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Regions Financial (RF) Tops Q2 EPS by 5c
- Spirit Blockchain Capital reports AGM results and board changes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
